Oral probiotic VSL#3 prevents autoimmune diabetes by modulating microbiota and promoting indoleamine 2,3-dioxygenase-enriched tolerogenic intestinal environment

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Dolpady, Jayashree ^a   Sorini, Chiara ^a   Di Pietro, Caterina ^a   Cosorich, Ilaria ^a   Ferrarese, Roberto ^a   Saita, Diego ^a   Clementi, Massimo ^a   Canducci, Filippo ^a,b   Falcone, Marika ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 33; PROBIOTIC AGENT; PROTEIN ZO1; RETINOIC ACID; VSL3; IL1B PROTEIN, MOUSE; IL33 PROTEIN, MOUSE; INFLAMMASOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BACTEROIDETES; CLOSTRIDIA; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DIABETES MELLITUS; ENTERITIS; FEMALE; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; INSULITIS; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLACEAE; LYMPHOCYTE DIFFERENTIATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREATIC LYMPH NODE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RIKENELLACEAE; TH1 CELL; TH17 CELL; AGE; ANIMAL; DIABETES MELLITUS, TYPE 1; DISEASE MODEL; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INTESTINE; METABOLISM; MICROBIOLOGY; NONOBESE DIABETIC MOUSE; ORAL DRUG ADMINISTRATION; TUMOR MICROENVIRONMENT;

ADMINISTRATION, ORAL; AGE FACTORS; ANIMALS; AUTOIMMUNITY; CELLULAR MICROENVIRONMENT; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INFLAMMASOMES; INTERLEUKIN-1BETA; INTERLEUKIN-33; INTESTINES; LACTOBACILLACEAE; MICE, INBRED NOD; PROBIOTICS; TH1 CELLS; TH17 CELLS; TRETINOIN;

EID: 84953255599     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/7569431     Document Type: Article

References (44)

1. M. Arumugam, J. Raes, E. Pelletier, et al., "Enterotypes of the human gut microbiome," Nature, vol. 473, pp. 174-180, 2011.
2. L. G. Albenberg and G. D. Wu, "Diet and the intestinal microbiome: associations, functions, and implications for health and disease," Gastroenterology, vol. 146, no. 6, pp. 1564-1572, 2014.
3. M. Murri, I. Leiva, J. M. Gomez-Zumaquero, et al., "Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study," BMC Medicine, vol. 11, no. 1, article 46, 2013.
4. A. Giongo, K. A. Gano, D. B. Crabb, et al., "Toward defining the autoimmune microbiome for type 1 diabetes," ISMEJournal, vol. 5, no. 1, pp. 82-91, 2011.
5. C. T. Brown, A. G. Davis-Richardson, A. Giongo, et al., "Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes," PLoS ONE, vol. 6, no. 10, Article ID e25792, 2011.
6. L. Wen, R. E. Ley, P. Y. Volchkov, et al., "Innate immunity and intestinal microbiota in the development of Type 1 diabetes," Nature, vol. 455, pp. 1109-1113, 2008.
7. F. Calcinaro, S. Dionisi, M. Marinaro, et al., "Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse," Diabetologia, vol. 48, no. 8, pp. 1565-1575, 2005.
8. K. Berer, M. Mues, M. Koutrolos, et al., "Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination," Nature, vol. 479, no. 7374, pp. 538-541, 2011.
9. C. Sorini and M. Falcone, "Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes," American Journal of Clinical and Experimental Immunology, vol. 2, pp. 156-171, 2013.
10. J. B. Meddings, J. Jarand, S. J. Urbanski, J. Hardin, and D. G. Gall, "Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat," American Journal of Physiology, vol. 276, no. 4, part 1, pp. G951-G957, 1999.
11. S. Graham, P. Courtois, W. J. Malaisse, J. Rozing, F. W. Scott, and A. M. Mowat, "Enteropathy precedes type 1 diabetes in the BB rat," Gut, vol. 53, no. 10, pp. 1437-1444, 2004.
12. F. Maurano, G. Mazzarella, D. Luongo, et al., "Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat," Diabetologia, vol. 48, no. 5, pp. 931-937, 2005.
13. A. D. Mooradian, J. E. Morley, A. S. Levine, W. F. Prigge, and R. L. Gebhard, "Abnormal intestinal permeability to sugars in diabetes mellitus," Diabetologia, vol. 29, no. 4, pp. 221-224, 1986.
14. R. Carratu, M. Secondulfo, L. De Magistris, et al., "Altered intestinal permeability to mannitol in diabetes mellitus type I," Journal of Pediatric Gastroenterology & Nutrition, vol. 28, no. 3, pp. 264-269, 1999.
15. M. Westerholm-Ormio, O. Vaarala, P. Pihkala, J. Ilonen, and E. Savilahti, "Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes," Diabetes, vol. 52, no. 9, pp. 2287-2295, 2003.
16. M. Secondulfo, D. Iafusco, R. Carratu, et al., "Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients," Digestive and Liver Disease, vol. 36, no. 1, pp. 35-45, 2004.
17. E. Badami, C. Sorini, M. Coccia, et al., "Defective differentiation of regulatory FoxP3+ T cells by small-intestinal dendritic cells in patients with type 1 diabetes," Diabetes, vol. 60, no. 8, pp. 2120-2124, 2011.
18. A. H?anninen, M. Salmi, O. Simell, and S. Jalkanen, "Mucosaassociated (β7-integrinhigh) lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior," Diabetes, vol. 45, no. 9, pp. 1173-1180, 1996.
19. J. Paronen, P. Klemetti, J. M. Kantele, et al., "Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDMexpress gut-specific homing receptor α4β7-integrin," Diabetes, vol. 46, no. 4, pp. 583-588, 1997.
20. S. Stosi?c-Grujici?c, T. Cvjeti?canin, and I. Stojanovi?c, "Retinoids differentially regulate the progression of autoimmune diabetes in three preclinicalmodels in mice,"Molecular Immunology, vol. 47, no. 1, pp. 79-86, 2009.
21. S. J. Zunino, D. H. Storms, and C. B. Stephensen, "Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice," Journal of Nutrition, vol. 137, no. 5, pp. 1216-1221, 2007.
22. E. Zagato, E. Mileti, L. Massimiliano, et al., "Lactobacillus paracasei CBA L74 metabolic products and fermented milk for infant formula have anti-inflammatory activity on dendritic cells in vitro and protective effects against colitis and an enteric pathogen in vivo," PLoS ONE, vol. 9, no. 2, Article ID e87615, 2014.
23. R. Mart?in, F. Chain, S. Miquel, et al., "Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation," Human Vaccines & Immunotherapeutics, vol. 10, no. 6, pp. 1611-1621, 2014.
24. L. Lefranc?ois and N. Lycke, "UNIT 3. 19 isolation ofmouse small intestinal intraepithelial lymphocytes, Peyers Patch, and lamina propria cells," in Current Protocols in Immunology, chapter 3, JohnWiley & Sons, 2001.
25. B. Weigmann, I. Tubbe, D. Seidel, A. Nicolaev, C. Becker, and M. F. Neurath, "Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue," Nature Protocols, vol. 2, no. 10, pp. 2307-2311, 2007.
26. J. R. Mora, M. Iwate, and U. H. vonAndrian, "Vitamineffectson the immune system: vitaminsAandDtake centre stage," Nature Reviews Immunology, vol. 8, no. 9, pp. 685-698, 2008.
27. K. Atarashi, T. Tanoue, T. Shima, et al., "Induction of colonic regulatory T cells by indigenous Clostridium species," Science, vol. 331, no. 6015, pp. 337-341, 2011.
28. K. Atarashi, T. Tanoue, K. Oshima, et al., "Treg induction by a rationally selected mixture of Clostridia strains fromthe human microbiota," Nature, vol. 500, no. 7461, pp. 232-236, 2013.
29. A. S. Fanning, B. J. Jameson, L. A. Jesaitis, and J. M. Anderson, "The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton," The Journal of Biological Chemistry, vol. 273, no. 45, pp. 29745-29753, 1998.
30. T. Strowig, J. Henao-Mejia, E. Elinav, and R. Flavell, "Inflammasomes in health and disease," Nature, vol. 481, no. 7381, pp. 278-286, 2012.
31. L. R. Lopetuso, F. Scaldaferri, and T. T. Pizarro, "Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis," Fibrogenesis and Tissue Repair, vol. 5, article 18, 2012.
32. L. R. Lopetuso, S. Chowdhry, and T. T. Pizarro, "Opposing functions of classic and novel IL-1 family members in gut health and disease," Frontiers in Immunology, vol. 4, article 181, 2013.
33. J. Satsangi, R. A. Wolstencroft, J. Cason, C. C. Ainley, D. C. Dumonde, and R. P. Thompson, "Interleukin 1 in Crohns disease," Clinical & Experimental Immunology, vol. 67, no. 3, pp. 594-605, 1987.
34. D. H. Munn and A. L. Mellor, "Indoleamine 2, 3 dioxygenase and metabolic control of immune responses," Trends in Immunology, vol. 34, no. 3, pp. 137-143, 2013.
35. G. Matteoli, E. Mazzini, I. D. Iliev, et al., "Gut CD103+ dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction," Gut, vol. 59, no. 5, pp. 595-604, 2010.
36. J. Schmitz, A. Owyang, E. Oldhamet al., "IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines," Immunity, vol. 23, no. 5, pp. 479-490, 2005.
37. T. Watts, I. Berti, A. Sapone, et al., "Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 8, pp. 2916-2921, 2005.
38. J. Visser, J. Rozing, A. Sapone, K. Lammers, and A. Fasano, "Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms," Annals of the New York Academy of Sciences, vol. 1165, pp. 195-205, 2009.
39. J. T. J. Visser, K. Lammers, A. Hoogendijk, et al., "Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat," Diabetologia, vol. 53, no. 12, pp. 2621-2628, 2010.
40. J. L. Coombes, K. R. R. Siddiqui, C. V. Arancibia-C?arcamo, et al., "A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-β-and retinoic acid-dependentmechanism," Journal of ExperimentalMedicine, vol. 204, no. 8, pp. 1757-1764, 2007.
41. C.-M. Sun, J. A. Hall, R. B. Blank, et al., "Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid," Journal of ExperimentalMedicine, vol. 204, no. 8, pp. 1775-1785, 2007.
42. E. Mazzini, L. Massimiliano, G. Penna, and M. Rescigno, "Oral tolerance can be established via gap junction transfer of fed antigens from CX3CR1+ macrophages to CD103+ dendritic cells," Immunity, vol. 40, no. 2, pp. 248-261, 2014.
43. K. Berer and G. Krishnamoorthy, "Commensal gut flora and brain autoimmunity: a love or hate affair?" Acta Neuropathologica, vol. 123, no. 5, pp. 639-651, 2012.
44. S. J. Turley, J.-W. Lee, N. Dutton-Swain, D. Mathis, and C. Benoist, "Endocrine self and gut non-self intersect in the pancreatic lymph nodes," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 49, pp. 17729-17733, 2005.